A carregar...
The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
New oral anticoagulants (NOACs; ie, direct thrombin inhibitor [DTI] and factor Xa [FXa] inhibitors) were used as alternatives to warfarin. Specific antidotes (idarucizumab for dabigatran and andexanet alfa for FXa inhibitors) and hemostatic reversal agents were used for lowering bleeding, but their...
Na minha lista:
| Publicado no: | Clin Appl Thromb Hemost |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714855/ https://ncbi.nlm.nih.gov/pubmed/30176738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029618796339 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|